Cg Oncology Inc [CGON] stock prices are down -3.90% to $24.18 at the moment. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The CGON shares have gain 11.43% over the last week, with a monthly amount glided 25.41%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Cg Oncology Inc [NASDAQ: CGON] stock has seen the most recent analyst activity on May 02, 2025, when JP Morgan initiated its Overweight rating and assigned the stock a price target of $41. Previously, Scotiabank started tracking the stock with Sector Perform rating on April 16, 2025, and set its price target to $23. On January 07, 2025, TD Cowen initiated with a Buy rating. UBS started tracking the stock assigning a Buy rating and suggested a price target of $60 on October 24, 2024. RBC Capital Mkts initiated its recommendation with a Outperform and recommended $66 as its price target on September 23, 2024. ROTH MKM started tracking with a Buy rating for this stock on August 28, 2024, and assigned it a price target of $65. In a note dated June 28, 2024, BofA Securities initiated an Buy rating and provided a target price of $65 on this stock.
The stock price of Cg Oncology Inc [CGON] has been fluctuating between $14.80 and $40.47 over the past year. Currently, Wall Street analysts expect the stock to reach $55 within the next 12 months. Cg Oncology Inc [NASDAQ: CGON] shares were valued at $24.18 at the most recent close of the market. An investor can expect a potential return of 127.46% based on the average CGON price forecast.
Analyzing the CGON fundamentals
The Cg Oncology Inc [NASDAQ:CGON] reported sales of 1.14M for trailing twelve months, representing a surge of 45500.00%. Gross Profit Margin for this corporation currently stands at 0.99% with Operating Profit Margin at -220.33%, Pretax Profit Margin comes in at -116.57%, and Net Profit Margin reading is -116.57%. To continue investigating profitability, this company’s Return on Assets is posted at -0.1, Equity is -0.11 and Total Capital is -0.19. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.0.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 23.65 points at the first support level, and at 23.11 for the second support level. However, for the 1st resistance point, the stock is sitting at 25.15, and for the 2nd resistance point, it is at 26.11.
Ratios To Look Out For
It’s worth pointing out that Cg Oncology Inc [NASDAQ:CGON]’s Current Ratio is 35.30. Also, the Quick Ratio is 35.30, while the Cash Ratio stands at 1.83. Considering the valuation of this stock, the price to sales ratio is 1616.70, the price to book ratio is 2.51.
Transactions by insiders
Recent insider trading involved POST LEONARD E, Director, that happened on Apr 28 ’25 when 1000.0 shares were sold. Director, POST LEONARD E completed a deal on Mar 17 ’25 to sell 1000.0 shares. Meanwhile, Director LEONARD E POST bought 4000.0 shares on Mar 17 ’25.
